Earnings call transcript: Sodexo lifts FY 2026 growth outlook after Q3 beat

Sodexo shares jumped 7.16% to $53.25 after the company reported Q3 FY2026 revenue of EUR 6.2B and raised its full-year organic growth target to 1.2%–1.5% from 0.5%–1.0%, citing stronger-than-expected organic growth (+2% vs expectations, helped by >15% organic growth at Sodexo Live! North America and +10.6% in rest of world). The company kept its operating margin guidance unchanged at 3.2%–3.4% despite the top-line upgrade, and guided Q4 to be “modestly positive” year-on-year with tougher comps and contract annualization effects. North America organic growth was -0.1% reported (-contract reclassification-adjusted to +2.2%), while healthcare and seniors remained resilient (7.8% organic growth in Q3).

Analysis

This reads less like a one-quarter beat and more like an early confirmation that the business is stabilizing after a period of under-earning. The market should reward the mix shift toward venues, airports, healthcare, and data-center-adjacent work because those buckets usually carry better pricing power and less salary compression than core education contracts. By contrast, peers with heavier education exposure or weaker event mix should lag if investors start underwriting a broader recovery in outsourced services.

The near-term catalyst is the July investor update plus the next print, where investors will test whether the raised organic outlook turns into operating leverage. The main falsifier is not revenue; it is margin absorption. If FY26 still lands in the same 3.2%-3.4% band and Q4 only confirms “modestly positive” growth, the move can fade as a re-rating story rather than a true earnings upgrade.

Contrarian view: the consensus is probably over-indexing on the revenue raise and underestimating the longer-dated commercial improvement signal, especially the better conversion rate and data-center pipeline. That said, the data-center opportunity is mostly a 2027+ story, so the stock may be ahead of itself if investors extrapolate immediate EPS acceleration. The best risk/reward is to own the quality of the recovery, not chase the first day’s gap unless follow-through confirms a new range above the prior high.

Key Decisions for Investors

• Long SDXAY on pullbacks over the next 1-3 weeks; use the raised guide and July investor day as catalysts. Target a move toward the 52-week high area, but cut if the stock fails to hold the post-print gain and trades back below the premarket breakout zone.
• If already long SDXAY, trim 20-30% into strength ahead of the July 16 investor update; the easy move is already in the tape and margin guidance is unchanged, so upside now depends on management proving operating leverage.
• Watch-list, not a buy: add only if Q4 commentary confirms net-new turns positive and education stabilizes. That is the first point where the thesis shifts from a revenue beat to a durable FY27 earnings setup.
• Avoid chasing higher-beta outsourcing peers until there is evidence the demand improvement is broadening beyond venues and healthcare; the cleaner beneficiary is SDXAY, while more education-heavy names remain at risk of lagging.